Glycolide
502-97-6O=C1COC(=O)CO1RKDVKSZUMVYZHH-UHFFFAOYSA-NABH001 is under investigation in clinical trial NCT01749306 (A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing).
502-97-6DTXSID8060115Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (93.3%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 45 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
1,4-Dioxane-2,5-dione is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of 1,4-Dioxane-2,5-dione are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
Status: Active Update: 08-07-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/20813
Plastics Material and Resin Manufacturing
1,4-Dioxane-2,5-dione: ACTIVE
Verwenden1,4-Dioxane-2,5-dione is used in the fabricating of artificial blood vessels.
Wird geladen…